ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

UCLA Comp Center status Near, But There Are Problems

October 22, 1976

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

NCI CTEP Approved Trials For the Month of December

December 27, 2013

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008